"SILVAMP TB LAM" rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South Africa.
journal contributionposted on 2020-11-12, 11:03 authored by Bianca Sossen, Tobias Broger, Andrew D Kerkhoff, Charlotte Schutz, Andre Trollip, Emmanuel Moreau, Samuel G Schumacher, Rosie Burton, Amy Ward, Robert J Wilkinson, David A Barr, Mark P Nicol, Claudia M Denkinger, Graeme Meintjes
Reducing diagnostic delay is key towards decreasing tuberculosis-associated deaths in people living with HIV. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.